Piper Sandler earnings up next: Can M&A momentum offset seasonal dip?

Piper Sandler is expected to report Q1 EPS of $3.81 on revenue of $446.31 million, implying sharp sequential declines of 44% and 33% from its unusually strong fourth quarter, though revenue would still rise 24.92% year over year. Analysts remain constructive with a Buy rating and $94.88 mean target, but EPS estimates have fallen 4.7% over the past two months, reflecting caution ahead of the print. Investors will focus on M&A pipeline commentary and whether recent expansion in Abu Dhabi can support growth beyond normal first-quarter seasonality.

Analysis

PIPR’s setup is less about the headline quarter and more about whether the firm can keep converting a cyclical rebound into durable operating leverage. The key second-order issue is that a smaller platform with concentrated senior-bank talent tends to benefit disproportionately when M&A re-accelerates, but it also de-risks the fastest when pipelines soften; that makes the stock more levered to changes in banker confidence and mandate wins than to broad market beta. If the first-quarter reset is followed by evidence of improving backlog, the multiple can re-rate quickly because the market is paying for earnings durability, not just peak-cycle comping.

The real risk is that consensus may still be extrapolating the prior quarter’s outperformance into a seasonally weak period, which could leave the stock vulnerable to a guidance miss even if the reported numbers look “fine” on a year-over-year basis. In that scenario, the first-order disappointment is EPS compression, but the second-order hit is to the forward revenue bridge: if management sounds cautious on closing timelines, sell-side models may need another leg down, and that matters more than the one-quarter print. Conversely, stabilization in estimate revisions over the past week suggests the selloff risk is more about commentary than the number itself.

The MENA expansion is the underappreciated call option. Near term, the Abu Dhabi hub is unlikely to move the P&L materially, but over 6-18 months it could improve access to high-fee advisory mandates where relationship coverage matters and cross-border deal execution is underpenetrated by U.S. boutiques. That creates a subtle competitive edge versus domestic peers if emerging-markets activity stays constructive, especially if U.S. large-cap M&A remains steady but not spectacular.

The contrarian view is that the market may be underpricing the asymmetry between a normal seasonal reset and an actual demand inflection. If deal activity merely normalizes instead of accelerating, the stock is probably fairly valued; if management signals stronger-than-expected pipeline conversion, there is room for a multiple expansion because current expectations still look cautious relative to the firm’s historical operating leverage.

Key Decisions for Investors

• Long PIPR into the print only on pullbacks below the low-$80s with a 3-6 month horizon; thesis is that a modestly better pipeline update can re-rate the forward multiple by 1-2 turns, while downside is limited if the quarter is merely seasonal.
• Hedge event risk with a short-dated call spread sale or buy puts around the earnings date if holding common stock; the risk/reward favors protection because the stock has already been marked against a strong prior quarter and the main catalyst is commentary, not headline EPS.
• Pair trade: long PIPR / short a more rate-sensitive investment bank or capital-markets name over the next 1-2 quarters; Piper’s sector focus and M&A mix should outperform if deal volumes improve unevenly rather than broad underwriting activity recovering uniformly.
• If management sounds constructive on MENA contribution and cross-border pipeline, add to PIPR on the first post-earnings pullback; that would signal the international expansion is becoming a real earnings option rather than a cost line.
• If guidance is cautious and estimate revisions restart downward, exit the long quickly and consider a tactical short for 2-4 weeks; the stock can de-rate fast if the market concludes the February beat was peak-cycle rather than repeatable.